Plasma proteomics profiling reveals differential protein expression in Alzheimer's and frontotemporal dementia
This observational cohort study analyzed plasma proteomics profiling using Olink Explore-HT in an Asian cohort of 101 individuals with known pTau217 status, focusing on Alzheimer's disease and frontotemporal dementia. The primary outcome was differential protein expression, with no comparator reported and follow-up duration not reported. Main results showed 1,168 proteins differentially expressed in Alzheimer's disease and 370 in frontotemporal dementia, both with FDR<0.05, along with distinct and overlapping proteomic signatures reflecting gliosis, synaptic dysfunction, immune activation, and metabolic pathways. Prioritized proteins correlated with cognitive performance and plasma phosphorylated tau, Aβ42, and neurofilament light chain, with strong concordance in cross-platform validation against large independent datasets. Safety and tolerability data were not reported. Key limitations include the cohort being limited to Asian individuals and reliance on plasma proteomics without tissue validation. The findings support a scalable framework for blood-based biologically informed targets for precision diagnosis and therapeutic stratification, but as associations from an observational study, they do not infer causation and have uncertain generalizability beyond this cohort.